General Information of DT
DT ID DTD0266
Gene Name SLC2A8
Protein Name Glucose transporter type 8
Gene ID
29988
UniProt ID
Q9NY64
TCDB ID
2.A.1.1.89
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 4LDS_A

Identity: 30.732%

Minimized Score: -782.893 kcal/mol

Detail: Structure Info

Synonyms GLUT-8; GLUT8; GLUTX1; Glucose transporter type X1; SLC2A8; Solute carrier family 2, facilitated glucose transporter member 8
DT Family Major Facilitator Superfamily (MFS)
Sugar Porter (SP) Family
Tissue Specificity Highly expressed in testis, but not intesticular carcinoma. Lower amounts present in most other tissues.
Function This insulin-regulated transporter facilitates glucose transport and binds cytochalasin B in a glucose-inhibitable manner. Seems to be a dual-specific sugar transporter as it is inhibitable by fructose.
Endogenous Substrate(s) Glucose
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(β) Post-translational Modification of This DT

(γ) Transcriptional Regulation of This DT

(δ) Epigenetic Regulation of This DT

Structural Variability Data of This DT (VARIDT 2.0)

(β) Inter-species Structural Differences

General Variability Data of This DT (VARIDT 1.0)

(β) Disease-specific Protein Abundances of This DT

(γ) Species- and Tissue-specific DT Abundances

Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Clinical Trial Drug

Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
2-Deoxyglucose
Phase 1/2 Drug Info Cancer 2A00-2F9Z [1]

Endogenous Metabolites (EMs) Handled by This DT

 Endogenous Metabolites (EMs)

Click to Show/Hide the Full List of EMs:            1 EMs in Total
EM Name PubChem CID Detail Experimental Material Ref
L-lactate
5460161
EM Info Identified using GLUT8-attenuated mice [2]

Drug-DT Affinity Assessed by Cell Line

 Clinical Trial Drug

Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
2-Deoxyglucose Phase 1/2 Drug Info Xenopus oocytes-GLUT8 Km = 2000 microM [1]
References
1 Functional Properties and Genomics of Glucose Transporters. Curr Genomics. 2007 Apr; 8(2): 113128.
2 GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts. Int J Cancer. 2017 Nov 15;141(10):2131-2142.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.